Leiming Xu

1.4k total citations
43 papers, 1.0k citations indexed

About

Leiming Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Leiming Xu has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Biomedical Engineering. Recurrent topics in Leiming Xu's work include Nanoplatforms for cancer theranostics (11 papers), Photodynamic Therapy Research Studies (7 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Leiming Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Photodynamic Therapy Research Studies (7 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Leiming Xu collaborates with scholars based in China, United States and Australia. Leiming Xu's co-authors include Chun-Ying Qu, Yingwei Chen, Jia Cao, Jiachun Yang, Manxiu Huai, Feng Shen, Fang Sun, Wensong Ge, Yongtao Xiao and Haijun Yu and has published in prestigious journals such as Advanced Materials, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Leiming Xu

42 papers receiving 994 citations

Peers

Countries citing papers authored by Leiming Xu

Since Specialization

Citations

This map shows the geographic impact of Leiming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leiming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leiming Xu more than expected).

Fields of papers citing papers by Leiming Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leiming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leiming Xu. The network helps show where Leiming Xu may publish in the future.

Co-authorship network of co-authors of Leiming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Leiming Xu. A scholar is included among the top collaborators of Leiming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leiming Xu. Leiming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic and functional characterization of the Pantoea ananatis nfd35 strain, a potential biocontrol agent of anthracnose disease in Trichosanthes kirilowii Maxim 2025 ·Physiological and Molecular Plant Pathology ·(unknown), Feng Zhu, Shuzhen Sun, Ying Zhang, Rui Min, Huixiang Yang, Leiming Xu, Dengke Yin, (unknown)	1
2	Smart drug delivery platforms reprogramming cancer immune cycle to mitigate immune resistance of pancreatic tumors 2025 ·Advanced Drug Delivery Reviews ·Ping Zhang, Jiaxing Pan, (unknown), Bo Peng, (unknown), Junjing Zhang, Leiming Xu, Yi Ling Lai, Haijun Yu, Zhiai Xu	2
3	Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification 2024 ·Journal of Nanobiotechnology ·Manxiu Huai, Yingjie Wang, (unknown), Jiaxing Pan, Fang Sun, Feiyu Zhang, Yi Zhang, Leiming Xu	6
4	Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma 2024 ·World Journal of Gastroenterology ·(unknown), (unknown), (unknown), (unknown), Manxiu Huai, Jiaxing Pan, Feiyu Zhang, Leiming Xu	32
5	Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted 2023 ·World Journal of Hepatology ·(unknown), Jiaxing Pan, Leiming Xu, (unknown), Yuanwen Chen	6
6	Self‐Adaptive Nanoregulator to Mitigate Dynamic Immune Evasion of Pancreatic Cancer 2023 ·Advanced Materials ·Jiaxing Pan, Yi Lai, Shunan Zhang, Huijuan Zhang, (unknown), Lujia Huang, Feng Wang, Haijun Yu, Leiming Xu, Zhiai Xu	21
7	Galanin ameliorates liver inflammation and fibrosis in mice by activating AMPK/ACC signaling and modifying macrophage inflammatory phenotype 2023 ·Frontiers in Immunology ·(unknown), Chao Huang, Hui Wang, (unknown), Jianbin Zhang, Leiming Xu, (unknown), Zhenghong Li, Yuanwen Chen	14
8	Risk factors for surgical compliance and impact on the survival of patients with glioma: a population-based propensity score-matched study 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Leiming Xu, Xudong Yang, (unknown), (unknown), Haijun Zhou	2
9	Multi-Task Refined Boundary-Supervision U-Net (MRBSU-Net) for Gastrointestinal Stromal Tumor Segmentation in Endoscopic Ultrasound (EUS) Images 2020 ·IEEE Access ·(unknown), (unknown), Fei Jiang, Leiming Xu, Feng Shen, (unknown), Yuanyuan Wang	15
10	Low-dose photodynamic therapy-induced increase in the metastatic potential of pancreatic tumor cells and its blockade by simvastatin 2020 ·Journal of Photochemistry and Photobiology B Biology ·Yujie Shen, Mingming Li, Fang Sun, Yi Zhang, Chun-Ying Qu, (unknown), Feng Shen, Leiming Xu	15
11	Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression 2020 ·World Journal of Gastroenterology ·Nannan Zheng, Min Zhou, Fang Sun, Manxiu Huai, Yi Zhang, Chun-Ying Qu, Feng Shen, Leiming Xu	33
12	Biodistribution and toxicity assessment of intratumorally injected arginine–glycine–aspartic acid peptide conjugated to CdSe/ZnS quantum dots in mice bearing pancreatic neoplasm 2018 ·Chemico-Biological Interactions ·Mingming Li, Jia Cao, Jiachun Yang, Yujie Shen, Xiaolei Cai, Yuanwen Chen, Chun-Ying Qu, Yi Zhang, Feng Shen, (unknown), Leiming Xu	15
13	Expression Changes of Long Noncoding RNA in the Process of Endothelial Cell Activation 2017 ·Cellular Physiology and Biochemistry ·Min Zhou, Wenjin Ding, Yingwei Chen, Feng Shen, Junyi Zeng, Chun-Ying Qu, (unknown), Leiming Xu	6
14	Effects of arginine–glycine–aspartic acid peptide-conjugated quantum dots-induced photodynamic therapy on pancreatic carcinoma in vivo 2017 ·International Journal of Nanomedicine ·Mingming Li, Jia Cao, Jiachun Yang, Yujie Shen, Xiaolei Cai, Yuanwen Chen, Chun-Ying Qu, Yi Zhang, Feng Shen, Leiming Xu	15
15	TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1 2017 ·Scientific Reports ·Jiachun Yang, Yi Zhang, Sijia He, Mingming Li, Xiaolei Cai, Hui Wang, Leiming Xu, Jia Cao	50
16	Galanin receptor 2 mediates antifibrogenic effects of galanin on hepatic stellate cells 2016 ·Experimental and Therapeutic Medicine ·(unknown), Zhenghong Li, Da Zhou, (unknown), Leiming Xu, Yuanwen Chen, Jian‐Gao Fan	8
17	Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy 2015 ·International Journal of Nanomedicine ·Leiming Xu, Chun-Ying Qu, Min Zhou, Yingwei Chen, Meimei Chen, Feng Shen	59
18	Depletion of Thymosin �4 Promotes the Proliferation, Migration, and Activation of Human Hepatic Stellate Cells 2014 ·Cellular Physiology and Biochemistry ·Yongtao Xiao, Chun-Ying Qu, Wensong Ge, (unknown), Jianxin Wu, Leiming Xu, Yingwei Chen	48
19	Effects of integrin-targeted photodynamic therapy on pancreatic carcinoma cell 2013 ·Zhonghua xiaohua zazhi ·(unknown), (unknown), Chun-Ying Qu, Min Zhou, Leiming Xu	1
20	miR-200b is involved in intestinal fibrosis of Crohn’s disease 2012 ·International Journal of Molecular Medicine ·Yingwei Chen, Wensong Ge, Leiming Xu, Chun-Ying Qu, Mingjie Zhu, Wenzhu Zhang, Yongtao Xiao	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact